Serum Triglyceride Elevation Following High-Dose Vitamin A Treatment for Pityriasis Rubra Pilaris

John C. Murray, Robert S. Gilgor, Gerald Sylvan Lazarus

Research output: Contribution to journalArticle

Abstract

• We describe two patients with pityriasis rubra pilaris in whom hypertriglyceridemia developed following the oral administration of high-dose vitamin A (retinol). The effects of transient hypertriglyceridemia are unknown, as both patients tolerated high-dose vitamin A therapy with minor, if any, other side effects. Both patients had minimal clinical improvement with this therapy. Patients being treated with 1,000,000 IU of vitamin A each day for ten to 14 days should have frequent determinations of serum lipid levels and liver function during the period of drug administration.

Original languageEnglish (US)
Pages (from-to)675-676
Number of pages2
JournalArchives of Dermatology
Volume119
Issue number8
DOIs
StatePublished - 1983
Externally publishedYes

Fingerprint

Pityriasis Rubra Pilaris
Vitamin A
Triglycerides
Hypertriglyceridemia
Serum
Therapeutics
Oral Administration
Lipids
Liver
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Dermatology

Cite this

Serum Triglyceride Elevation Following High-Dose Vitamin A Treatment for Pityriasis Rubra Pilaris. / Murray, John C.; Gilgor, Robert S.; Lazarus, Gerald Sylvan.

In: Archives of Dermatology, Vol. 119, No. 8, 1983, p. 675-676.

Research output: Contribution to journalArticle

@article{002e96c3e1a948babc00ec6c1e158cbd,
title = "Serum Triglyceride Elevation Following High-Dose Vitamin A Treatment for Pityriasis Rubra Pilaris",
abstract = "• We describe two patients with pityriasis rubra pilaris in whom hypertriglyceridemia developed following the oral administration of high-dose vitamin A (retinol). The effects of transient hypertriglyceridemia are unknown, as both patients tolerated high-dose vitamin A therapy with minor, if any, other side effects. Both patients had minimal clinical improvement with this therapy. Patients being treated with 1,000,000 IU of vitamin A each day for ten to 14 days should have frequent determinations of serum lipid levels and liver function during the period of drug administration.",
author = "Murray, {John C.} and Gilgor, {Robert S.} and Lazarus, {Gerald Sylvan}",
year = "1983",
doi = "10.1001/archderm.1983.01650320049015",
language = "English (US)",
volume = "119",
pages = "675--676",
journal = "JAMA Dermatology",
issn = "2168-6068",
publisher = "American Medical Association",
number = "8",

}

TY - JOUR

T1 - Serum Triglyceride Elevation Following High-Dose Vitamin A Treatment for Pityriasis Rubra Pilaris

AU - Murray, John C.

AU - Gilgor, Robert S.

AU - Lazarus, Gerald Sylvan

PY - 1983

Y1 - 1983

N2 - • We describe two patients with pityriasis rubra pilaris in whom hypertriglyceridemia developed following the oral administration of high-dose vitamin A (retinol). The effects of transient hypertriglyceridemia are unknown, as both patients tolerated high-dose vitamin A therapy with minor, if any, other side effects. Both patients had minimal clinical improvement with this therapy. Patients being treated with 1,000,000 IU of vitamin A each day for ten to 14 days should have frequent determinations of serum lipid levels and liver function during the period of drug administration.

AB - • We describe two patients with pityriasis rubra pilaris in whom hypertriglyceridemia developed following the oral administration of high-dose vitamin A (retinol). The effects of transient hypertriglyceridemia are unknown, as both patients tolerated high-dose vitamin A therapy with minor, if any, other side effects. Both patients had minimal clinical improvement with this therapy. Patients being treated with 1,000,000 IU of vitamin A each day for ten to 14 days should have frequent determinations of serum lipid levels and liver function during the period of drug administration.

UR - http://www.scopus.com/inward/record.url?scp=0020573099&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020573099&partnerID=8YFLogxK

U2 - 10.1001/archderm.1983.01650320049015

DO - 10.1001/archderm.1983.01650320049015

M3 - Article

C2 - 6870321

AN - SCOPUS:0020573099

VL - 119

SP - 675

EP - 676

JO - JAMA Dermatology

JF - JAMA Dermatology

SN - 2168-6068

IS - 8

ER -